120,000 Shares in iShares Biotechnology ETF $IBB Purchased by Henshaw Capital LLC

Posted by Max Byerly on Aug 2nd, 2026

Henshaw Capital LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 120,000 shares of the financial services provider’s stock, valued at approximately $20,262,000. Henshaw Capital LLC owned 0.26% of iShares Biotechnology ETF at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in IBB. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $25,000. Basepoint Wealth LLC acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $26,000. Cary Street Partners Financial LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter valued at approximately $29,000. Copia Wealth Management purchased a new position in iShares Biotechnology ETF in the 4th quarter valued at approximately $34,000. Finally, Caitlin John LLC acquired a new position in iShares Biotechnology ETF during the fourth quarter worth $34,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 1.9%

IBB opened at $186.41 on Friday. iShares Biotechnology ETF has a one year low of $130.25 and a one year high of $199.05. The business’s fifty day moving average is $181.72 and its two-hundred day moving average is $174.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were paid a $0.0238 dividend. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Company Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.